Antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA : addressing the vulnerable populations

This document aims to support the strengthening of antenatal screening (ANS) programmes for HIV, hepatitis B (HBV), syphilis and rubella susceptibility in the general population and in groups identified as vulnerable to motherto- child-transmission (MTCT) in the EU/EEA. Vulnerable groups specifically targeted by this guidance include: 1) migrant women and women from ethnic minority groups; 2) women engaging in high-risk behaviour or with a partner at high risk for HIV, HBV and syphilis infections; and 3) women belonging to minority groups refusing vaccinations. The target audience of this document includes policymakers and national antenatal screening programme coordinators in the EU/EEA Member States.